Multiple Sclerosis (MS)

Biologic and specialty medications for MS · Insurance handled · Free delivery

Key Takeaways

MS disease-modifying therapies (DMTs) are highly effective at reducing relapse rates and slowing progression
Anti-CD20 biologics (Ocrevus, Kesimpta) are among the most effective MS DMTs available
Early treatment is strongly associated with better long-term outcomes
BiologicHealthPlus handles prior authorization, insurance appeals, and free delivery for MS medications

What Is Multiple Sclerosis?

Multiple sclerosis (MS) is a chronic autoimmune disease in which the immune system attacks the myelin sheath — the protective coating around nerve fibers — in the central nervous system. This disrupts nerve signal transmission, causing a wide range of neurological symptoms. MS affects approximately 1 million people in the United States and is the most common disabling neurological disease of young adults.

Types of MS

Relapsing-Remitting MS (RRMS)

Most common form (~85% at diagnosis). Characterized by episodes of new or worsening symptoms (relapses) followed by periods of partial or full recovery.

Secondary Progressive MS (SPMS)

Many RRMS patients eventually develop SPMS, with steadily worsening neurological function with or without relapses.

Primary Progressive MS (PPMS)

~10–15% of MS cases. Characterized by steadily worsening neurological function from disease onset without early relapses.

Clinically Isolated Syndrome (CIS)

A first episode of MS-like symptoms. Early treatment after CIS can delay conversion to definite MS.

Biologic & Specialty Medications for MS

Medication	Class	Route	MS Type
Ocrevus (ocrelizumab)	Anti-CD20	IV infusion q6mo	RRMS, PPMS
Kesimpta (ofatumumab)	Anti-CD20	SQ monthly	RRMS, active SPMS
Tysabri (natalizumab)	Anti-integrin	IV infusion q4wk	RRMS (highly active)
Lemtrada (alemtuzumab)	Anti-CD52	IV infusion (courses)	RRMS (highly active, risk REMS)
Aubagio (teriflunomide)	Pyrimidine synthesis inhibitor	Oral daily	RRMS, CIS
Tecfidera / Vumerity (dimethyl fumarate)	Nrf2 activator	Oral twice daily	RRMS

Most commercial insurance plans and Medicare Part B (for IV infusions) or Part D (for self-administered MS medications) cover FDA-approved disease-modifying therapies. Prior authorization is required for all MS DMTs. BiologicHealthPlus verifies your specific insurance coverage and handles all PA filings at no charge.

MS disease-modifying therapies have high list prices — typically $60,000–$100,000+ per year. However, most commercially insured patients pay $0–$50/month through manufacturer copay assistance programs. Uninsured patients may receive medications free through Patient Assistance Programs. BiologicHealthPlus identifies all available savings options at no charge.

MS is managed by neurologists, typically those with specialty training in MS (MS specialists). If you have been recently diagnosed, your primary care physician can provide a referral to a neurologist. BiologicHealthPlus works with neurologists across all 50 states to coordinate specialty pharmacy services for MS patients.

💊 BiologicHealthPlus Supports MS Patients

Insurance verification, prior authorization, copay enrollment, and free delivery for MS specialty medications.

Check My MS Coverage →

📚 Sources & Further Reading

BiologicHealthPlus follows medical consensus from leading health organizations. The following authoritative sources were used in developing this page:

🔗

What Is MS?National MS Society

🔗

Multiple SclerosisWikipedia

🔗

MS Clinical ReviewNIH / NCBI

🔗

Multiple SclerosisMayo Clinic

Medical Disclaimer: Content is for educational purposes only and reviewed by the BiologicHealthPlus Clinical Team. Always consult your healthcare provider for personalized medical advice. Last reviewed: August 2026.

Medical Disclaimer: Educational information only. MS treatment decisions must be made with a neurologist. Last updated: July 2026.